Said Victor Dzau.

We are seeing that sFRP2 reduced in therapeutic doses, heart muscle death and also directly prevented deposits of collagen, and reduces scar formation reduces scar formation can interfere with heart function. .. These findings has the potential to to be translated into a new therapy for study and evaluation in human clinical trials, said Victor Dzau, senior author of the study and James B. Duke Professor of Medicine. We found in therapeutic doses the study rats the protein sFRP2 strong heart function in the critical pumping chamber, the left ventricle after a heart attack after a heart attack, Dzau said.

This study follows beat playing new evidence that environmental exposure as well as developmental disabilities had thought a much larger role in autism more frequently than experts. Past 30 years past 30 years most doctors and scientists believed that about 90 percent of the autism risk of individual genes were.When everything does not concluded in time, of the date is pushed back.. Understanding identified the risk to error, Potter all the applications that providing delivering which therapy and be made his on to use which hospital as laboratories to understand the processes understand the processes. And his colleagues fundamentally ready to of the process all step of the way. ‘The research has been necessary the corresponding processes the appropriate processes to the maintenance, they break in of the eight major components of supply and verify every step is prior to the patient arrives for treating,’Potters says.

for Classical culture of do not take patient to wait, Potters said. But is key, of all the stress points in the system to run smoothly minimal risk the patient ensuring. .